PB1807: OUTCOME OF CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA IN CHILDREN AND ADOLESCENTS: A SINGLE CENTER EXPERIENCE

PB1807: OUTCOME OF CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA IN CHILDREN AND ADOLESCENTS: A SINGLE CENTER EXPERIENCE

Bibliographic Details
Main Authors:	N. Ben Sayed, G. Abichou, E. Bouselema, H. Regaieg, Y. Ben Youssef, A. Khelif
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000850080.74457.fa

Similar Items

PB1807: THE SIGNIFICANCE OF MOLECULAR RISK FACTORS IN ACUTE MYELOID LEUKEMIA
by: Alla Gordienko, et al.
Published: (2023-08-01)

PB1739: ADVERSE EFFECTS OF ASPARAGINASE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
by: Wafa Chenbah, et al.
Published: (2023-08-01)

Invasive infection caused by Geotrichum capitatum in three patients with acute myeloid leukemia
by: Sana Rouis, et al.
Published: (2020-09-01)

PB2069: ELTROMBOPAG WITH IMMUNO SUPPRESSIVE THERAPY IN SEVERE ACQUIRED APLASTIC ANEMIA IN CHILDREN AND ADOLESCENTS: A MONOCENTRIC EXPERIENCE
by: Nesrine Ben Sayed, et al.
Published: (2023-08-01)

PB1812: CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA IN PEDIATRIC POPULATION: THE RESULTS OF A MONOCENTRIC EXPERIENCE
by: H. Charfi, et al.
Published: (2022-06-01)

PB2262: PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKINN LYMPHOMA
by: Kmira Zahra, et al.
Published: (2023-08-01)

PB2263: TOXICITY PROFILE OF SALVAGE CHEMOTHERAPY REGIMENS IN PATIENTS WITH RELAPSED/ REFRACTORY HODGKIN LYMPHOMA.
by: Kmira Zahra, et al.
Published: (2023-08-01)

PB2556: MEGALOBLASTIC ANEMIA: EPIDEMIOLOGICAL, CLINICAL, AND ETIOLOGICAL PROFILE: ABOUT 200 CASES.
by: Kmira Zahra, et al.
Published: (2023-08-01)

Detection of KIT mutations in core binding factor acute myeloid leukemia
by: Passant Badr, et al.
Published: (2018-01-01)

PB2238: ATYPICAL CHRONIC MYELOID LEUKEMIA. CLINICAL AND MOLECULAR FEATURES. A SINGLE CENTER EXPERIENCE.
by: Javier Alberto Rojas Martínez, et al.
Published: (2023-08-01)

PB1843: ACUTE MYELOID LEUKEMIA WITH PHILADELPHIA CHROMOSOME: EXPERIENCE OF SFAX HEMATOLOGY DEPARTMENT
by: N. Siala, et al.
Published: (2022-06-01)

PB1767: OUTCOME OF RELAPSED CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN THE SOUTH OF TUNISIA SINGLE CENTER EXPERIENCE
by: N. Siala, et al.
Published: (2022-06-01)

Clinical and experimental efficacy of gemtuzumab ozogamicin in core binding factor acute myeloid leukemia
by: Michele Gottardi, et al.
Published: (2017-09-01)

A novel t(3;12)(q21;p13) translocation in a patient with accelerated chronic myeloid leukemia after imatinib and nilotinib therapy
by: Ayda Bennour, et al.
Published: (2013-03-01)

PB2241: CHARACTERISTICS AND OUTCOME OF WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA) IN ADULTS: A RETROSPECTIVE ANALYSIS OF 110 TUNISIAN PATIENTS
by: E. Bouslama, et al.
Published: (2022-06-01)

PB1836: ACUTE MYELOID LEUKEMIA IN OLDER ADULTS IN RESOURCE CONSTRAINT SETTING: SINGLE CENTER DATA FROM SOUTH INDIA
by: M. Paul, et al.
Published: (2022-06-01)

PB1842: EARLY DEATH IN NEWLY DIAGNOSED ADULT ACUTE MYELOID LEUKEMIA
by: N. Siala, et al.
Published: (2022-06-01)

PB2092: PRIMARY BONE DIFFUSE LARGE B CELL LYMPHOMA: A SINGLE CENTER EXPERIENCE
by: G. Abichou, et al.
Published: (2022-06-01)

Acute myeloid leukemia in elderly patients: experience of a single center
by: Rodrigues C.A., et al.
Published: (2003-01-01)

Clinical characteristics and prognostic factors analysis of core binding factor acute myeloid leukemia in real world
by: Yamei Zhai, et al.
Published: (2023-12-01)

An ETV6::NTRK3 fusion transcript in a core‐binding factor acute myeloid leukemia
by: Lucie Coster, et al.
Published: (2023-08-01)

PB1832: INFLAMMATION INDUCED COAGULATION IN ACUTE MYELOID LEUKEMIA
by: Olivera Mitrović Ajtić, et al.
Published: (2023-08-01)

PB1782: INTEGRATIVE MOLECULAR SUBTYPES OF ACUTE MYELOID LEUKEMIA
by: Qianxing Mo, et al.
Published: (2023-08-01)

PB2006: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH PLASMA CELL LEUKEMIA (PCL): A SINGLE-CENTER STUDY FROM TUNISIA
by: Y. Fakhfakh, et al.
Published: (2022-06-01)

Acute Myeloid Leukemia: Is It T Time?
by: Meriem Ben Khoud, et al.
Published: (2021-05-01)

Single Center Study of Prescribing and Treatment Outcomes of Patients with Chronic Myeloid Leukemia
by: Ladan Nekoohesh, et al.
Published: (2020-01-01)

PB1824: IMPACT OF DAY 15 BONE MARROW ASPIRATION ON PREDICTION OF COMPLETE REMISSION AND RELAPSE IN ACUTE MYELOID LEUKEMIA
by: R. Kharrat, et al.
Published: (2022-06-01)

Subsets of natural killer cells in chronic myeloid leukemia and their relation with some inflammatory cytokines
by: Yusur Falah Faraj, et al.
Published: (2023-01-01)

PB1910: CHRONIC MYELOID LEUKEMIA AND RELATIONSHIP TO SECONDARY SOLID NEOPLASMS
by: M. J. Ramos, et al.
Published: (2022-06-01)

PB1832: ARTERIAL THROMBOSIS AND ACUTE MYELOID LEUKEMIA – IS THERE A CONNECTION?
by: N. Pantic, et al.
Published: (2022-06-01)

PB1900: COVID-19 IMPACT ON CHRONIC MYELOID LEUKEMIA PATIENTS
by: S.-M. Galdean, et al.
Published: (2022-06-01)

PB1847: ACUTE MYELOID LEUKEMIA – IS IT MORE BESIDES GENETIC ABNORMALITIES?
by: M. Urbano, et al.
Published: (2022-06-01)

PB1801: MYCN IS REQUIRED FOR MAINTAINING AN ONCOGENIC CHARACTERISTICS OF LEUKEMIA CELLS IN ACUTE MYELOID LEUKEMIA
by: Nanfang Huang, et al.
Published: (2023-08-01)

Infection Prevalence in Adolescents and Adults With Acute Myeloid Leukemia Treated in an Indian Tertiary Care Center
by: Hasmukh Jain, et al.
Published: (2020-11-01)

Cytogenetic profile of adult acute myeloid leukemia in Egypt: a single-center experience
by: Mohamed G. Elnaggar, et al.
Published: (2022-10-01)

EXTRAMEDULLARY INVOLVEMENT IN ACUTE MYELOID LEUKEMIA. A SINGLE CENTER TEN YEARS EXPERIENCE
by: Luana Fianchi, et al.
Published: (2021-04-01)

Childhood core binding factor (CBF) acute myeloid leukemia and its association with French American British (FAB) classification
by: Naeem Jabbar, et al.
Published: (2020-10-01)

Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.
by: Wenlan Chen, et al.
Published: (2016-01-01)

Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3”
by: K. H. Begna, et al.
Published: (2022-04-01)

PB1811: REAL LIFE APPLICATION OF NEXT GENERATION SEQUENCING IN ACUTE MYELOID LEUKEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS: A SINGLE CENTER EXPERIENCE
by: Giulia Gabrielli, et al.
Published: (2023-08-01)